Cargando…
Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi
BACKGROUND: Malawi experienced prolonged use of sulfadoxine/pyrimethamine (SP) as the front-line anti-malarial drug, with early replacement of chloroquine and delayed introduction of artemisinin-based combination therapy. Extended use of SP, and its continued application in pregnancy is impacting th...
Autores principales: | Ravenhall, Matt, Benavente, Ernest Diez, Mipando, Mwapatsa, Jensen, Anja T. R., Sutherland, Colin J., Roper, Cally, Sepúlveda, Nuno, Kwiatkowski, Dominic P., Montgomery, Jacqui, Phiri, Kamija S., Terlouw, Anja, Craig, Alister, Campino, Susana, Ocholla, Harold, Clark, Taane G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129638/ https://www.ncbi.nlm.nih.gov/pubmed/27899115 http://dx.doi.org/10.1186/s12936-016-1634-6 |
Ejemplares similares
-
Changing the policy for intermittent preventive treatment with sulfadoxine–pyrimethamine during pregnancy in Malawi
por: Mwendera, Chikondi A., et al.
Publicado: (2017) -
Genetic diversity of the Plasmodium falciparum GTP-cyclohydrolase 1, dihydrofolate reductase and dihydropteroate synthetase genes reveals new insights into sulfadoxine-pyrimethamine antimalarial drug resistance
por: Turkiewicz, Anna, et al.
Publicado: (2020) -
Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania
por: Kavishe, Reginald A., et al.
Publicado: (2016) -
Corrigendum to “Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes” [Int. J. Parasitol. Drugs and Drug Resist. 7 (2017) 174–180]
por: Gomes, Ana Rita, et al.
Publicado: (2017) -
Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes
por: Gomes, Ana Rita, et al.
Publicado: (2017)